"Additional monitoring of kidney function may be needed when starting, or increasing, doses of GLP-1 medications." Kidney Care UK The frequency of follow-up tests should match the patients CKD stage and individual risks
Influence of long-term anti-seizure medications on redox parameters in human blood
Results reveal predispositions in GLP-1 receptor sensitivity, GIP pathway signaling, and baseline weight regulation mechanisms
The study will conclude in 2027 with results anticipated in early 2028
Less frequent but more serious risks include pancreatitis, gallbladder issues, and in rare cases, thyroid tumors
We have told you exactly what is behind it, which is two separate evidence bases and a hypothesis nobody has tested